Using a Commercial Evaluation Authorisation in AICIS

You've got a promising new ingredient, maybe a novel plant extract or an active you sourced from a smaller specialty supplier, and it's not on Australia's Inventory yet. Before you commit fully to a formal introduction process, there's a middle path worth knowing about: a commercial evaluation authorisation, which exists precisely for the situation where you want to test market response before going all in.

What a commercial evaluation is for

The core idea behind this route is letting you introduce a limited quantity of a new industrial chemical, including a cosmetic ingredient that isn't already on the Inventory, specifically for evaluation purposes, things like gauging customer interest, running small trial batches, or testing a limited market response, rather than for full-scale commercial introduction from day one.

This matters because full introduction categorization under AICIS is built around understanding risk at the volume and use pattern you're actually planning for. If you don't yet know whether a product built around this ingredient will sell at meaningful volume, going through the heavier process for full-scale introduction can be more effort than the situation calls for. A commercial evaluation authorisation is scoped to that in-between reality: you're not just doing lab research, but you're also not yet committing to ongoing full-scale supply.

What it does and doesn't let you do

Because the exact volume caps, duration limits, and specific conditions attached to a commercial evaluation authorisation are set within AICIS's own current rules and can be updated, this is a case where you genuinely want to check the current AICIS guidance directly rather than relying on a rough secondhand description. What's safe to say in general terms:

• It's designed for evaluation and limited-scale activity, not as a permanent substitute for full introduction if you plan to scale up.
• It sits alongside, not instead of, the standard Inventory and categorization framework, meaning it's a specific authorised pathway with its own conditions rather than a general exemption from AICIS oversight.
• If your evaluation goes well and you want to move to ongoing commercial supply at real volume, you'll typically need to transition into the appropriate full introduction category rather than simply continuing indefinitely under the evaluation authorisation.

Why this route suits small and handmade brands

A lot of the makers who'd benefit most from this pathway are exactly the small-batch, growth-stage brands who don't want to over-invest in a full regulatory process for an ingredient that might not even resonate with customers. If you're testing whether a new botanical serum sells before you commit to sourcing that extract at real production volume, a commercial evaluation authorisation lets you get real product into real hands on a limited basis while you make that call, rather than forcing an all-or-nothing decision upfront.

A sensible way to approach it

1. Confirm the ingredient genuinely isn't on the Inventory before assuming you need this route at all. Search by the correct current name and any CAS number, since naming mismatches are a common false alarm.
2. Get clear on your actual evaluation goals and scale. Knowing roughly how much product you want to test and over what timeframe helps you understand whether this pathway fits your situation.
3. Check AICIS's current published requirements for this authorisation type directly, since the specific conditions, documentation, and limits are the kind of detail that's best confirmed at the source rather than assumed.
4. Plan your path forward before you need it. If the evaluation goes well, know roughly what full introduction would involve so you're not starting from zero when it's time to scale.

Keeping the paperwork trail clean either way

Whether you end up going through a commercial evaluation authorisation or straight to full introduction, the groundwork is the same: a precise INCI and CAS identification of the ingredient, clear documentation from your supplier, and an honest read on your actual volume and use plans. Cosmetic Comply's ingredient mapping, expanding supplier blends into their real components and matching everything to INCI names and CAS numbers, gives you that clean starting point whether you're filing a Canadian CNF today or preparing formulas for Australia's different, chemical-based framework.